MARTIN ANDREANSKY to Anemia, Sickle Cell
This is a "connection" page, showing publications MARTIN ANDREANSKY has written about Anemia, Sickle Cell.
Connection Strength
0.423
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 04; 99(4):785-788.
Score: 0.172
-
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2022 03; 28(3):174.e1-174.e5.
Score: 0.148
-
A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. Blood. 2016 11 24; 128(21):2561-2567.
Score: 0.103